FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Lannett Lisdexamfetamine Dimesylate Capsules Recall

Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by…

Lannett Company Inc. · Seymour, IN

Risk level
Class II
Reported by FDA
Sep 3, 2025
Recall ID
D-0599-2025
Check your lot numberHow we source this data

Summary

Lannett recalled Lisdexamfetamine Dimesylate Capsules starting Aug 11, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0599-2025 on Sep 3, 2025. Reason: Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg. Status: Terminated.

Why it was recalled

Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.

Product description

Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37

Lot numbers, UPCs & expiration codes

Lot #: 25280726A, Exp. Date 03/2027

Where it was sold

Nationwide within the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0599-2025
Classification
Class II
Status
Terminated
Recall initiated
Aug 11, 2025
FDA report date
Sep 3, 2025
Quantity
8544 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Lannett Company Inc.

Original FDA data

Every field from FDA enforcement report D-0599-2025, exactly as published.

Show all FDA fields
City
Seymour
State
IN
Status
Terminated
Country
United States
Event ID
97397
Address
1101 C Ave W
Code information
Lot #: 25280726A, Exp. Date 03/2027
Postal code
47274-3342
Report date
Sep 3, 2025
Product type
Drugs
Recall number
D-0599-2025
Classification
Class II
Recalling firm
Lannett Company Inc.
Product quantity
8544 bottles
Termination date
Jun 24, 2026
Reason for recall
Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37
Distribution pattern
Nationwide within the USA
Recall initiation date
Aug 11, 2025
Initial firm notification
Letter
Center classification date
Aug 25, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0599-2025, published Sep 3, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls